Back to News
Market Impact: 0.2
Psyence BioMed Establishes Texas Entity To Advance U.S. Ibogaine Development
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Psyence Biomedical formed Texas Ibogaine Research Corporation (TIRC) to coordinate its U.S. ibogaine-development activities. TIRC will focus on pharmaceutical-grade supply and regulatory engagement, supporting the company’s efforts to advance ibogaine-based programs in the U.S.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
PBM0.45
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- Wendy's shares jump 15% as Nelson Peltz's Trian offers $1.4 billion to buy burger chain
- Fortinet’s stock is taking a dive after earnings. Here’s why.
- RBC Capital cuts Sprouts Farmers Market stock rating on margin concerns
- Microsoft's Big Bets on AI Start to Pay Off